Form4.ai tracks every SEC insider trade in real time. See every APGE insider filing with a free account — no card.
See every APGE insider filing — free account, no card.
Free accountApogee Therapeutics, Inc. (APGE) has 8 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $832K. Most recent filing: Sept. 3, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 3, 2026 SEC filing | Fairmount Funds Management LLC Director | Other | — | — |
| Sep 3, 2026 SEC filing | McKenna Mark C. Director | Other | — | — |
| Sep 3, 2026 SEC filing | Fox Jennifer A. Director | Other | — | — |
Create a free account to see all 8 APGE filings from the last 90 days. No card needed.
Create free accountWant APGE insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.